Agonist and antagonist coast

Fertility and Sterility

Volumn 97, Issue 3, 2012, Pages 523-526

  Aboulghar, Mohamed ^a,b  

^a EGYPTIAN IVF ET CENTER   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

coasting; GnRH antagonist; OHSS

Indexed keywords

CHORIONIC GONADOTROPIN; DOPAMINE RECEPTOR STIMULATING AGENT; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; VASCULOTROPIN;

APOPTOSIS; ASCITES; CELL DEATH; COASTING; CRYOPRESERVATION; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EMBRYO TRANSFER; ESTROGEN BLOOD LEVEL; FERTILIZATION; FERTILIZATION IN VITRO; FLOW CYTOMETRY; GENE EXPRESSION; GRANULOSA CELL; HEMOCONCENTRATION; HIGH RISK PATIENT; HORMONAL THERAPY; HOSPITAL ADMISSION; HUMAN; INCIDENCE; OOCYTE; OOCYTE RETRIEVAL; OVARIAN STIMULATION; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVULATION; OVULATION INDUCTION; PATIENT SAFETY; PERITONEAL FLUID; PREGNANCY RATE; PREVENTION AND CONTROL; PRIORITY JOURNAL; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION;

EID: 84857783127     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.01.094     Document Type: Article

References (39)

1. B. Rizk, and M. Aboulghar Modern management of ovarian hyperstimulation syndrome Hum Reprod 6 1991 1082 1087
2. M. Aboulghar, and R. Mansour Ovarian hyperstimulation syndrome: classification and critical analysis of preventive measures Hum Reprod Update 9 2003 275 289
3. A. Golan, R. Ron-El, A. Herman, Z. Weinraub, Y. Soffer, and E. Caspi Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for invitro fertilization Fertil Steril 50 1988 912 916
4. Bilan FIVNAT responses aux stimulation de L'ovulation dans les procreations medicalement assistes (PMA) Contracept Fertil Sex 18 1989 592 594
5. H.G. Al-Inany, and M. Aboulghar GnRH antagonists for assisted reproduction: a Cochrane review Hum Reprod 17 2002 874 885
6. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum Reprod Update 12 2006 651 671
7. H.G. Al-Inany, A.M. Abou-Setta, and M. Aboulghar Gonadotrophin-releasing hormone antagonist for assisted conception Cochrane Database Syst Rev 19 3 2006 CD001750
8. H.G. Al-Inany, M.A.F.M. Youssef, M. Aboulghar, F.J. Broekmans, M.D. Sterrenburg, and J.G. Smit Gonadotrophin-releasing hormone antagonists for assisted reproductive technology Cochrane Database Syst Rev 11 5 2011 CD001750
9. D. Bodri, S.K. sunkara, and A. Coomarasamy Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis Fertil Steril 95 2001 164 169
10. P. Humaidan, E.G. Papanikolaou, D. Kyrou, B. Alsbjerg, N.P. Polyzos, P. Devroey, and H.M. Fatemi The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives Reprod Biomed Online 2011 Nov 9 [Epub ahead of print]
11. R. Mansour, M. Aboulghar, G. Serour, Y. Amin, and A.M. Abou-Setta Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome Hum Reprod 20 2005 3167 3172
12. J. Rabinovici, O. Kushnir, J. Shalev, M. Goldenberg, and J. Blankstein Rescue of menotropin cycles prone to develop ovarian hyperstimuation Br J Obstet Gynecol 94 1987 1098 1102
13. G. Sher, R. Salem, M. Feinman, S. Dedge, C. Zouves, and V. Knotzen Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer Obstet Gyneco 81 1993 1009 1011
14. A. Delvigne, and S. Rozenberg Preventive attitude of physicians to avoid OHSS in IVF patients Hum Reprod 16 2001 2491 2495
15. M. Aboulghar Coasting: what is the cost? Current Women's Health Review 6 2010 239 244
16. M. Aboulghar Symposium: Update on prediction and management of OHSS. Prevention of OHSS Reprod Biomed Online 19 2009 33 42
17. H. Abdalla, and J.D.M. Nicopoullos The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1068 coasted cycles to prevent ovarian hyperstimulation Fertil Steril 94 2010 1757 1763
18. A. Delvigne, and S. Rozenberg A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients Hum Reprod Update 8 2002 291 296
19. P. Kovács, S. Mátyás, and S.G. Kaali Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders Fertil Steril 85 2006 913 917
20. L. Moreno, I. Diaz, A. Pacheco, A. Zúñiga, A. Requena, and J.A. Garcia-Velasco Extended coasting duration exerts a negative impact on IVF cycle outcome due to premature luteinization Reprod Biomed Online 9 2004 500 504
21. J.A. Garcia-Velasco, V. Isaza, G. Quea, and A. Pellicer Coasting for the prevention of ovarian hyperstimulaiton syndrome: much ado about nothing? Fertil Steril 85 2006 547 554
22. M. Owj, ESh Tehrani Nejad, E. Amirchaghmaghi, Z. Ezabadi, and A.R. Baghestani The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles Eur J Obstet Gynecol Reprod Biol 133 2007 81 85
23. O. Levinsohn-Tavor, S. Friedler, M. Schachter, A. Raziel, D. Strassburger, and R. Ron-El Coasting-what is the best formula? Hum Reprod 18 2003 937 940
24. M.A. Aboulghar Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS Hum Reprod 18 2003 1140 1141
25. J.A. Garcia-Velasco, A. Zúñiga, A. Pacheco, R. Gomez, C. Simon, J. Remohi, and A. Palliver Coasting acts through downregulation of VEGF gene expression and protein secretion Hum Reprod 19 2004 1530 1538
26. A. D'Angelo, J. Brown, and N.N. Amso Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome Cochrane Database Syst Rev 15 6 2011 CD002811
27. P.E. Egbase, M. Al Sharhan, and J.G. Grudzinskas Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study Hum Reprod 14 1999 1421 1425
28. A. Aflatoonian, I. Mahani, N. Tabibnejad, B. Aflatoonian, and R. Aflatoonian Comparison of coasting with aspiration half of follicles before hCG injection for prevention of OHSS in ART cycles June 18-21, 2006 ESHRE Prague, Czech Republic
29. M. Aboulghar, R. Mansour, Y. Amin, H. Al-Inany, M. Aboulghar, and G. Serour A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS Reprod Biomed Online 15 2007 271 279
30. V. Kamthane, S. Goswami, S. Ghosh, R. Chattopadhay, and B. Chakravarty Does coasting prevent OHSS without compromising pregnancy outcome? Hum Reprod 19 Suppl(6) 2004 i121
31. A. Delvigne, C. Carlier, and S. Rozenberg Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle? Fertil Steril 76 2001 844 846
32. H.M. Fatemi, P. Platteau, C. Albano, A. Van Steirteghem, and P. Devroey Rescue IVF and coasting with the use of a GnRH antagonist after ovulation induction Reprod Biomed Online 5 2002 273 275
33. J. Farhi, A. Ben-Haroush, Y. Lande, O. Sapir, H. Pinkas, and B. Fisch In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus FnRH antagonist protocols Fertil Steril 91 2009 377 382
34. P. Devroey, N.P. Polyzos, and C. Blockeel An OHSS-Free clinic by segmentation of IVF treatment Hum Reprod 26 2011 2593 2597
35. F. Martinez, D.B. Rodriguez, R. Buxaderas, R. Tur, F. Mancini, and B. Coroleu GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports Fertil Steril 95 2001 2432
36. T.G. Lainas, I.A. Sfontouris, I.Z. Zorzovilis, G.K. Petsas, G.T. Lainas, and E.M. Kolibianakis Management of severe early ovarian hyperstimualiton syndrome by re-initiation of GnRH antagonist Reprod Biomed Online 15 2007 408 412
37. F.M. Bonilla-Musoles, F. Raga, J.C. Castillo, M. Sanz, M. Dolz, and N. Osborne High doses of GnRH antagonists are efficient in the management of severe ovarian hyperstimulation syndrome Clin Exp Obstet Gynecol 36 2009 8 81
38. T.G. Lainas, I.A. Sfontouris, I.Z. Zorsovill, G.K. Petsas, G.T. Lainas, and G.S. Illiadis Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol Reprod Biomed Online 18 2009 15 20
39. N.L. Rollene, M.H. Amols, S.B. Hudson, and C.C. Coddingron Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series Fertil Steril 92 2009 1169